Clinical Trials

Can open source by applied to pharma R&D? This is the aim of Molecule.

"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."

Male animal bias in preclinical research isn’t scientifically justified and may be skewing our understanding of the brain.

A new vaccine could help give people at risk of HIV more options.

Pfizer’s latest investment in the UK targets an improvement in pediatric clinical trials.

Clinical trials need an overhaul – and AI is the solution.

Our animation explores the unique challenges a "no-deal" Brexit poses for the drug development and advanced therapy sectors.

Orphan drugs for rare diseases represent a significant unmet medical need for pharma, but commercialication can be tricky...

Artificial Intelligence and other innovative technologies have the potential to disrupt every stage of the clinical trial process.

With cell and gene therapies being all the rage, we take a peek at some of the advanced therapies coming down the pipe.